2006Chinese Journal of HypertensionRequires access

Effect of Pancreatic Kininogenase on Ventriculer Remodeling in Spontaneously Hypertensive Rats

Fu Ju

Open publisher page 0 citations

Abstract

Objective To investigate the effect of pancreatic kininogenase on the expression of matrix metalloproteinases-2 2(MMP-2), transfer growth factor-β_ 1 (TGF-β_ 1 ) and ventriculer remodeling in spontaneously hypertensive rats (SHR). Methods Twenty-four male 15 weeks SHR were randomly divided into three groups: SHR group, pancreatic kininogenase treatment group(PK: 7.2 U/kg·d), captopril treatment group(Cap: 10 mg/kg·d)(n=8 in each), 8 Wister Kyoto were served as control. After four weeks, blood pressure were measured througth carotid artery catherization. Myocardial tissue was stained with VG and pathological changes were studied. MMP-2, TGF-β_ 1 were determined by immunohisto-chemical technique(SP method). Results In pancreatic kininogenase treated SHR, SBP(183±12 vs SHR: 234±23)mm Hg, LVMI(2.89±0.15 vs SHR: 3.06±0.18)mg/g, CVF(0.17±0.03 vs SHR: 0.26±0.05)%, PVCA(0.57±0.26 vs SHR: 0.99±0.47)% and expression of MMP-2, TGF-β_ 1 in SHR were significantly improved (P0.05). All indexs were significantly decresed, and were close to captopril group. Conclusion Pancreatic kinigenase significantly reversed LVMI, CVF and PVCA, which may be mediated by attenuating expression of MMP-2 and TGF-β_1 in myocardial tissue.

About this research paper

What this paper is about

Objective To investigate the effect of pancreatic kininogenase on the expression of matrix metalloproteinases-2 2(MMP-2), transfer growth factor-β_ 1 (TGF-β_ 1 ) and ventriculer remodeling in spontaneously hypertensive rats (SHR). Methods Twenty-four male 15 weeks SHR were randomly divided into three groups: SHR group, pancreatic kininogenase treatment group(PK: 7.2 U/kg·d), captopril treatment group(Cap: 10 mg/kg·d)(n=8 in each), 8 Wister Kyoto were served as control. After four weeks, blood pressure were measured througth carotid artery catherization. Myocardial tissue was stained with VG and pathological changes were studied. MMP-2, TGF-β_ 1 were determined by immunohisto-chemical technique(SP method). Results In pancreatic kininogenase treated SHR, SBP(183±12 vs SHR: 234±23)mm Hg, LVMI(2.89±0.15 vs SHR: 3.06±0.18)mg/g, CVF(0.17±0.03 vs SHR: 0.26±0.05)%, PVCA(0.57±0.26 vs SHR: 0.99±0.47)% and expression of MMP-2, TGF-β_ 1 in SHR were significantly improved (P0.05). All indexs were significantly decresed, and were close to captopril group. Conclusion Pancreatic kinigenase significantly reversed LVMI, CVF and PVCA, which may be mediated by attenuating expression of MMP-2 and TGF-β_1 in myocardial tissue.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effect of pancreatic kininogenase on the expression of matrix metalloproteinases-2 2(MMP-2), transfer growth factor-β_ 1 (TGF-β_ 1 ) and ventriculer remodeling in spontaneously hypertensive rats (SHR). Methods Twenty-four male 15 weeks SHR were randomly divided into three groups: SHR group, pancreatic kininogenase treatment group(PK: 7.2 U/kg·d), captopril treatment group(Cap: 10 mg/kg·d)(n=8 in each), 8 Wister Kyoto were served as control. After four weeks, blood pressure were measured througth carotid artery catherization. Myocardial tissue was stained with VG and pathological changes were studied. MMP-2, TGF-β_ 1 were determined by immunohisto-chemical technique(SP method). Results In pancreatic kininogenase treated SHR, SBP(183±12 vs SHR: 234±23)mm Hg, LVMI(2.89±0.15 vs SHR: 3.06±0.18)mg/g, CVF(0.17±0.03 vs SHR: 0.26±0.05)%, PVCA(0.57±0.26 vs SHR: 0.99±0.47)% and expression of MMP-2, TGF-β_ 1 in SHR were significantly improved (P0.05). All indexs were significantly decresed, and were close to captopril group. Conclusion Pancreatic kinigenase significantly reversed LVMI, CVF and PVCA, which may be mediated by attenuating expression of MMP-2 and TGF-β_1 in myocardial tissue.

Key concepts: Captopril, Internal medicine, Endocrinology, Matrix metalloproteinase, Medicine, Blood pressure, Pathological, Transforming growth factor

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of Pancreatic Kininogenase on Ventriculer Remodeling in Spontaneously Hypertensive Rats — Research Paper | ScholarLens